Breast cancer is the most common cancer among women worldwide [1]. Accurate preoperative estimation of the tumor size is instrumental in tumor stage estimation, planning the treatment, and ensuring negative resection margins [2, 3]. In particular, in patients scheduled to undergo neoadjuvant chemotherapy,...
Testicular tumors are relatively uncommon in humans, constituting approximately 1% of all male malignancies [1]. Despite its relatively low overall incidence, testicular cancer is the most common solid tumor in men aged 20 to 34 years [2]. Due to the potential for tumor metastasis and infiltration, biopsy...
Esophageal cancer is a common malignancy of the digestive tract. According to the current global cancer statistics, it has the seventh and sixth highest incidence and mortality rates, respectively [1]. Based on the CROSS and NEOCRTEC5010 studies, neoadjuvant chemoradiotherapy (NCRT) and radical esophagectomy...
Pelvic and sacral tumors (PSTs) are rare and complex, posing significant challenges for diagnosis and treatment due to their anatomical location and diverse tissue characteristics [1, 2]. These tumors, whether primary or secondary, typically present as large soft tissue masses that can invade surrounding...
Positron Emission Tomography-Computed Tomography using Prostate-Specific Membrane Antigen (PSMA PET/CT) has emerged as a promising novel imaging modality in the management of prostate cancer (PCa) patients. PSMA PET/CT has been primarily applied in detecting PCa recurrence after primary treatment, and...